Medicare Pilot Program Offers GLP-1 Discounts, Excludes Certain Patients

Why it matters locally: Virginia's senior population and individuals with severe illnesses relying on Medicare could be directly affected by the eligibility criteria of this new GLP-1 medication pilot program.

Medicare has introduced a pilot program aimed at streamlining access to GLP-1 medications. Under this initiative, some seniors pay $50 per month for these drugs. However, the program's structure means that many individuals with severe illnesses do not qualify for this reduced rate. Jeff La Marca, for example, received a prescription for the weight-loss drug Zepbound in January. He faced a monthly cost of $750 for the medication.